Songjiang Ma, President at GYRE THERAPEUTICS, INC. (GYRE), sold 4,000 shares at $10.14 ($41K) on 2025-03-10, disclosed to the SEC on 2025-03-11.
Scheduled sale ($41k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.13 | 1,906 | $19K | 47.4% |
| 2 | $12.14 | 41 | $498 | 1.2% |
| 3 | $13.03 | 53 | $691 | 1.7% |
| 4 | $10.14 | 2,000 | $20K | 49.7% |
| Total | $10.19 avg | 4,000 | $41K | 100% |
| Filing → |
| GYRE | SELL | 2025-05-22 | $44K | — | Filing → |
| GYRE | SELL | 2025-05-20 | $45K | — | Filing → |
| GYRE | SELL | 2025-05-16 | $22K | — | Filing → |